Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Therapeutic Advances in Neurological Disorders
|
December 25, 2025
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)
Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado, et al.
Neurology and Therapy
|
June 9, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
Piero Barbanti, Cinzia Aurilia, Massimo Filippi, et al.
Cephalalgia : an International Journal of Headache
|
June 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study)
Claudia Altamura, Luigi Francesco Iannone, Flavia Lo Castro, et al.
Journal of Neurology
|
May 7, 2025
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II)
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache
|
February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)
Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
Cephalalgia : an International Journal of Headache
|
March 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability
Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis, et al.
The Journal of Headache and Pain
|
October 2, 2025
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)
Piero Barbanti, Giulia Fiorentini, Cecilia Camarda, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Therapeutic Advances in Neurological Disorders
|
December 25, 2025
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)
Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado, et al.
Neurology and Therapy
|
June 9, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
Piero Barbanti, Cinzia Aurilia, Massimo Filippi, et al.
Cephalalgia : an International Journal of Headache
|
June 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study)
Claudia Altamura, Luigi Francesco Iannone, Flavia Lo Castro, et al.
Journal of Neurology
|
May 7, 2025
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II)
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache
|
February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)
Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
Cephalalgia : an International Journal of Headache
|
March 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability
Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis, et al.
The Journal of Headache and Pain
|
October 2, 2025
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)
Piero Barbanti, Giulia Fiorentini, Cecilia Camarda, et al.
Page
of 7